Louvet, Christophe <br/><br/>
[Olaparib and pancreatic cancer: A challenging Lesson].  [electronic resource] 

 -  Bulletin du cancer  Sep 2019 
 - 715-716 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1769-6917 
<br/><br/><label>Standard No.: </label>10.1016/j.bulcan.2019.07.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Agents--therapeutic use<br/>Clinical Trials, Phase III as Topic<br/>Genes, BRCA1<br/>Genes, BRCA2<br/>Germ-Line Mutation<br/>Humans<br/>Pancreatic Neoplasms--drug therapy<br/>Phthalazines--therapeutic use<br/>Piperazines--therapeutic use<br/>Placebos<br/>Progression-Free Survival<br/>Randomized Controlled Trials as Topic